ZEVALIN® (ibritumomab tiuxetan) - Targeted. Proven. Today.

Links shared publicly online about this topic.

  • 0
    total visits

ZEVALIN® (ibritumomab tiuxetan) - Targeted. Proven. Today.

zevalin.com —

ZEVALIN (ibritumomab tiuxetan) from Spectrum Pharmaceuticals is a CD20-directed radiotherapeutic antibody.

View full resource at zevalin.com

Tags: Pharma, FDA

  • Share

Most Recently Shared on November 21, 2011 at 10:02 pm By:

Chemo101 Kristin Gustafson

FDA removes bioscan requirements from Zevalin http://t.co/DKkvbkNd

6 months ago...

Reply

Retweet

Favorite

Advertisement